Clinical Specialty Portfolio

ANTI-INFECTIVES & ANTIBACTERIALS

3 Formulations

Broad-spectrum potentiated aminopenicillin formulations engineered with clavulanate to overcome beta-lactamase resistance.

Clinical Focus

Pediatric Bacterial Infections, Acute Otitis Media, Sinusitis & RTI

Key Molecules:AmoxicillinPotassium Clavulanate

Marketed Formulations in Anti-Infectives & Antibacterials

Each product is formulated in compliance with strict Indian Pharmacopoeia assay standards.

View Full Catalogue

REXCLAV 625 (Amoxicillin & Potassium Clavulanate Tablets I.P.) - Anti-infective packaging by RexCure Pharma

Film-coated Tablets

Schedule H Rx

REXCLAV 625

Amoxicillin & Potassium Clavulanate Tablets I.P.

Potent broad-spectrum antibacterial formulation combining Amoxicillin with Clavulanic Acid to combat beta-lactamase resistant pathogens.

Composition: Amoxicillin Trihydrate IP equivalent to Amoxicillin 500 mg, Potassium Clavulanate Diluted IP equivalent to Clavulanic Acid 125 mg, Excipients q.s.

Pack: 10 × 10 Tablets

View Details

REXCLAV 457 DS (Amoxicillin & Potassium Clavulanate Oral Suspension IP (DS)) - Anti-infective packaging by RexCure Pharma

Dry Syrup with Sterile Water

Schedule H Rx

REXCLAV 457 DS

Amoxicillin & Potassium Clavulanate Oral Suspension IP (DS)

Potentiated broad-spectrum pediatric antibiotic dry suspension formulated in 7:1 ratio to eradicate resistant pathogens.

Composition: Amoxicillin Trihydrate IP eq. to Amoxicillin 400 mg, Potassium Clavulanate Diluted IP eq. to Clavulanic Acid 57 mg, Per 5 ml reconstituted

Pack: Bottle (30 ml Reconstituted)

View Details

REXCLAV 228.5 (Amoxicillin & Potassium Clavulanate Oral Suspension IP) - Anti-infective packaging by RexCure Pharma

Dry Syrup with Sterile Water

Schedule H Rx

REXCLAV 228.5

Amoxicillin & Potassium Clavulanate Oral Suspension IP

Standard-strength broad-spectrum pediatric antibacterial suspension for community-acquired childhood infections.

Composition: Amoxicillin Trihydrate IP eq. to Amoxicillin 200 mg, Potassium Clavulanate Diluted IP eq. to Clavulanic Acid 28.5 mg, Per 5 ml reconstituted

Pack: Bottle (30 ml Reconstituted)

View Details

Return to All Therapeutic Areas